PALM BEACH, Fla. — The U.S. health care system is not functioning in a sustainable way, new National Association of Chain Drug Stores chairman Martin Otto said at the organization’s Annual Meeting here last month. Costs are too high and are rising fast, while outcomes are disappointing. “There are a number of structural issues in
The National Association of Chain Drug Stores reports that final average manufacturer price (AMP)-based federal upper limits (FULs) are set to be published by the Centers for Medicare & Medicaid Services (CMS) late this month. Once instituted, the final AMP-based FULs will “significantly change” Medicaid pharmacy reimbursement for branded and generic drugs, according to NACDS.
WASHINGTON — The Centers for Medicare & Medicaid Services (CMS) has issued the Covered Outpatient Drugs final rule with comment, which the National Association of Chain Drug Stores said includes “significant changes” to Medicaid pharmacy reimbursement for generic drugs based on the average manufacturer price (AMP) model. Released on Thursday and due to be published